U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
8151181511Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Mellitus on Basal Plus Mealtime InsulinCompletedHas ResultsType 2 Diabetes MellitusDrug: HOE901-U300 (new formulation of insulin glargine)|Drug: Lantus (insulin glargine)https://ClinicalTrials.gov/show/NCT01499082
8151281512Urinary Nerve Growth Factor (NGF), Prostaglandin E2 (PGE2)and Adenosine Triphosphate (ATP): Potential Biomarkers in Overactive Bladder PatientsRecruitingNo Results AvailableOveractive BladderDrug: Oxybutinin, Fesoterodine, Solifenacin, Propiverin, Trospiumhttps://ClinicalTrials.gov/show/NCT01499069
8151381513Mesenchymal Stem Cell Transplantation in Osteoarthritis of Hip JointCompletedNo Results AvailableHip OsteoarthritisBiological: stem cell injectionhttps://ClinicalTrials.gov/show/NCT01499056
8151481514Pilot Study of PLX3397 in Patients With Advanced Castration-Resistant Prostate Cancer (CRPC)CompletedNo Results AvailableProstate CancerDrug: PLX3397https://ClinicalTrials.gov/show/NCT01499043
8151581515[Trial of device that is not approved or cleared by the U.S. FDA]WithheldNo Results Availablehttps://ClinicalTrials.gov/show/NCT01499030
8151681516A Single Dose Study Of PF-06291874 In Healthy Adult SubjectsTerminatedNo Results AvailableHealthyDrug: PF-06291874 or placebo|Drug: PF-06291874 or Placebohttps://ClinicalTrials.gov/show/NCT01499017
8151781517A Phase 1 Study To Evaluate The Pharmacokinetics And Safety Of Three Modified Release And One Immediate Release Formulations Of Tofacitinib (CP-690,550) In Healthy VolunteersCompletedNo Results AvailableHealthyDrug: tofacitinib (CP-690,550) modified-release formulation A|Drug: tofacitinib (CP-690,550) modified-release formulation B1|Drug: tofacitinib (CP-690,550) modified-release formulation A|Drug: tofacitinib (CP-690,550) modified-release formulation B1|Drug: tofacitinib (CP-690,550) modified-release formulation B2|Drug: tofacitinib (CP-690,550) immediate-release formulationhttps://ClinicalTrials.gov/show/NCT01499004
8151881518Spinal Cord Injury Leg RehabilitationRecruitingNo Results AvailableSpinal Cord Injury|Paraplegia|Quadriplegia|TetraplegiaDevice: AMES Treatmenthttps://ClinicalTrials.gov/show/NCT01498991
8151981519Ipilimumab in Combination With Androgen Suppression Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate CancerRecruitingNo Results AvailableAdenocarcinoma of the Prostate|Hormone-resistant Prostate Cancer|Recurrent Prostate Cancer|Stage IV Prostate CancerBiological: ipilimumab|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT01498978
8152081520The Cork BASELINE Birth Cohort StudyActive, not recruitingNo Results AvailableFood Allergy|Eczema|Obesityhttps://ClinicalTrials.gov/show/NCT01498965
8152181521MEDI-573 in Combination With SOC in Unresectable or Metastatic HCC.CompletedNo Results AvailableUnresectable or Metastatic Hepatocellular Carcinoma (HCC)Drug: MEDI-573 (1 of 3 doses)|Drug: Sorafenibhttps://ClinicalTrials.gov/show/NCT01498952
8152281522Pharmacokinetics of Insulin Detemir in Healthy Chinese Male SubjectsCompletedNo Results AvailableDiabetes|HealthyDrug: insulin detemirhttps://ClinicalTrials.gov/show/NCT01498939
8152381523Comparison of Two Insulin Detemir Formulations in Healthy VolunteersCompletedNo Results AvailableDiabetes|HealthyDrug: insulin detemir|Drug: insulin detemirhttps://ClinicalTrials.gov/show/NCT01498926
8152481524Observational Study of NovoNorm® in Subjects With DiabetesCompletedNo Results AvailableDiabetes|Diabetes Mellitus, Type 2Drug: repaglinidehttps://ClinicalTrials.gov/show/NCT01498913
8152581525An Observational Study Evaluating Efficacy, Safety and Convenience of NovoNorm® in Treatment of Type 2 Diabetes in Routine Clinical PracticeCompletedNo Results AvailableDiabetes|Diabetes Mellitus, Type 2Drug: repaglinidehttps://ClinicalTrials.gov/show/NCT01498900
8152681526Efficacy of Fingolimod in de Novo Patients Versus Fingolimod in Patients Previously Treated With a First Line Disease Modifying TherapyRecruitingNo Results AvailableRelapsing Remitting Multiple SclerosisDrug: Fingolimod (FTY720)https://ClinicalTrials.gov/show/NCT01498887
8152781527Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne VulgarisCompletedNo Results AvailableAcne VulgarisDrug: Placebo|Drug: gevokizumab|Drug: gevokizumabhttps://ClinicalTrials.gov/show/NCT01498874
8152881528Drug Interaction Study Between Dolutegravir and an Oral Contraceptive Containing Norgestimate and EthinylestradiolCompletedNo Results AvailableInfection, Human Immunodeficiency VirusDrug: Ortho-Cyclen|Drug: Dolutegravir|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01498861
8152981529Effect of Cooking Oils on Whole Blood and Saliva Fatty Acids in Children in Bogota, ColombiaCompletedNo Results AvailableComplianceDietary Supplement: Cooking oilshttps://ClinicalTrials.gov/show/NCT01498848
8153081530Safety Study of Preoperative Sunitinib and Radiation in Soft Tissue SarcomaCompletedNo Results AvailableSoft Tissue SarcomaDrug: Sunitinibhttps://ClinicalTrials.gov/show/NCT01498835
8153181531Levetiracetam Versus Oxcarbazepine as Monotherapy to Evaluate Efficacy and Safety in Subjects With Newly or Recently Diagnosed Partial EpilepsyCompletedHas ResultsEpilepsyDrug: Levetiracetam|Drug: Oxcarbazepinehttps://ClinicalTrials.gov/show/NCT01498822
8153281532Blood Pressure and Brain Blood Flow Regulation After Midodrine Administration in Those With Spinal Cord InjuryCompletedNo Results AvailableOrthostatic IntoleranceDrug: Midodrinehttps://ClinicalTrials.gov/show/NCT01498809
8153381533KITS Study -Ketorolac In Tonsillectomy Surgery: a Double Blinded, Randomized Clinical TrialRecruitingNo Results AvailableRecurrent Acute TonsillitisDrug: Ketorolac|Drug: Normal Salinehttps://ClinicalTrials.gov/show/NCT01498796
8153481534Phase I Study of 5-Fluorouracil in Children and Young Adults With Recurrent EpendymomaCompletedNo Results AvailableCentral Nervous System Malignancies|EpendymomaDrug: 5-fluorouracilhttps://ClinicalTrials.gov/show/NCT01498783
8153581535An Observational Drug Utilization Study of Asenapine in the United Kingdom (P08308)Active, not recruitingNo Results AvailableBipolar DisorderDrug: Asenapine|Drug: Aripiprazole|Drug: Quetiapine|Drug: Risperidone|Drug: Olanzapine|Drug: Ziprasidone|Drug: Iloperidone|Drug: Paliperidone|Drug: Lurasidone|Drug: Clozapine|Drug: Amisulpride|Drug: Sertindole|Drug: Zotepinehttps://ClinicalTrials.gov/show/NCT01498770
8153681536Genome-wide Association StudyTerminatedNo Results AvailableEsophageal Squamous Cell Carcinoma.https://ClinicalTrials.gov/show/NCT01498757
8153781537Randomized Controlled Trial of Antibiotics in the Management of Children With Community-Acquired Skin and Soft Tissue Abscess Undergoing Incision and DrainageRecruitingNo Results AvailableSkin and Soft Tissue Abscess|Methicillin-resistant Staphylococcus Aureus (MRSA) InfectionDrug: Oral Clindamycinhttps://ClinicalTrials.gov/show/NCT01498744
8153881538Effect of the Biomarker Copeptin in Managing Patients With Suspected Acute Coronary Syndrome (ACS)CompletedNo Results AvailableAcute Myocardial InfarctionBehavioral: Discharge homehttps://ClinicalTrials.gov/show/NCT01498731
8153981539Seasonal Influenza DNA Vaccine Prime With Trivalent Inactivated Vaccine (TIV) Boost Compared to TIV AloneCompletedNo Results AvailableInfluenzaBiological: DNA vaccine|Biological: TIVhttps://ClinicalTrials.gov/show/NCT01498718
8154081540The Natural History of Procalcitonin in Hemorrhagic StrokeWithdrawnNo Results AvailableIntraventricular Hemorrhage|Intracerebral HemorrhageOther: Procalcitonin levelhttps://ClinicalTrials.gov/show/NCT01498705

* Görseller ve İçerik tekif hakkına sahip olabilir